GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (XPAR:EAPI) » Definitions » Research & Development

Euroapi (XPAR:EAPI) Research & Development : €30 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Euroapi's Research & Development for the six months ended in Dec. 2023 was €16 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was €30 Mil.

Euroapi Research & Development Historical Data

The historical data trend for Euroapi's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi Research & Development Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
16.30 19.90 17.00 21.80 29.60

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial 7.00 11.40 10.40 13.30 16.30

Euroapi Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euroapi  (XPAR:EAPI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Euroapi Research & Development Related Terms

Thank you for viewing the detailed overview of Euroapi's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Euroapi (XPAR:EAPI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (XPAR:EAPI) » Definitions » Research & Development
Comparable Companies
XPAR:BOI XPAR:AB XPAR:MLCOT XPAR:ALRPD XPAR:VETO ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NBIX NSE:DIVISLAB BOM:500124 VTRS SZSE:000963
Traded in Other Exchanges
EAPIF:USA 940:Germany
Address
15 rue Traversiere, Paris, FRA, 75012
Website
https://www.euroapi.com
Euroapi SA offers both API Solutions and Contract Development and Manufacturing Organization CDMO. The company provides expertise in Quality, Regulatory and Supply and have dedicated commercial teams for its clients around the globe.

Euroapi (XPAR:EAPI) Headlines

No Headlines